Nose bleeds associated with use of risperidone

British Medical Journal

Volumn 328, Issue 7453, 2004, Pages 1416-

  Harrison Woolrych, Mira ^a,b   Clark, David W J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; RISPERIDONE; SEROTONIN ANTAGONIST;

CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG MONITORING; EPISTAXIS; HEADACHE; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY; THROMBOCYTOPENIA;

ADULT; EPISTAXIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISPERIDONE; SEROTONIN ANTAGONISTS;

EID: 2942720705     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Assion HJ, Kolbinger HM, Rao ML, Laux G. Lymphocytopenia and thrombocytopenia during treatment with risperidone or dozapine. Pharmacopsychiatry 1996;29:227-8.
2. Satomura K, Takase B, Hamabe A, Ashida K, Hosaka H, Ohsuzu F, et al. Sarpogrelate, a specific 5HT2-receptor antagonist, improves the coronary microcirculation in coronary artery disease. Clin Cardiol 2002;25:28-32.
3. Physicians Desk Reference. 54th ed. Montvale, NJ: Medical Economics, 2000:1456.